All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Steering CommitteeAbout UsNewsletterContact
Visit:
ALL HubAML HubGVhD HubMDS HubMPN HubMultiple Myeloma
Steering CommitteeAbout UsNewsletterContact
SubtypesTherapeuticsCongressesTrialsExpert Opinions

Prof. Nathan Fowler | ICML 2017 | Long-term follow-up of lenalidomide + rituximab in iNHL

By Anne Villeneuve
Featured
Nathan Fowler
Jun 22, 2017
Share:

Long-term follow-up of lenalidomide + rituximab in iNHL

Share:
More about...
ICML 2017Indolent B-cell lymphomasLenalidomideRituximab

Related articles

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox